231 related articles for article (PubMed ID: 31415795)
1. A novel transthyretin/STAT4/miR-223-3p/FBXW7 signaling pathway affects neovascularization in diabetic retinopathy.
Shao J; Fan G; Yin X; Gu Y; Wang X; Xin Y; Yao Y
Mol Cell Endocrinol; 2019 Dec; 498():110541. PubMed ID: 31415795
[TBL] [Abstract][Full Text] [Related]
2. Transthyretin affects the proliferation and migration of human retinal microvascular endothelial cells in hyperglycemia via hnRNPA2B1.
Gu Y; Hu D; Xin Y; Shao J
Biochem Biophys Res Commun; 2021 Jun; 557():280-287. PubMed ID: 33894415
[TBL] [Abstract][Full Text] [Related]
3. The interface targeting hnRNPA2B1 regulates the repression of transthyretin against human retinal microvascular endothelial cells in high-glucose environment.
Tian Y; Ye L; Shao J; Xin Y
Diabet Med; 2023 Sep; 40(9):e15125. PubMed ID: 37186403
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy.
Wang L; Liu WX; Huang XG
Exp Mol Pathol; 2020 Oct; 116():104488. PubMed ID: 32622012
[TBL] [Abstract][Full Text] [Related]
5. Transthyretin represses neovascularization in diabetic retinopathy.
Shao J; Yao Y
Mol Vis; 2016; 22():1188-1197. PubMed ID: 27746673
[TBL] [Abstract][Full Text] [Related]
6. Transthyretin Upregulates Long Non-Coding RNA MEG3 by Affecting PABPC1 in Diabetic Retinopathy.
Fan G; Gu Y; Zhang J; Xin Y; Shao J; Giampieri F; Battino M
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847264
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA MALAT1 participates in the pathological angiogenesis of diabetic retinopathy in an oxygen-induced retinopathy mouse model by sponging miR-203a-3p.
Yu L; Fu J; Yu N; Wu Y; Han N
Can J Physiol Pharmacol; 2020 Apr; 98(4):219-227. PubMed ID: 31689123
[TBL] [Abstract][Full Text] [Related]
8. Transthyretin Exerts Pro-Apoptotic Effects in Human Retinal Microvascular Endothelial Cells Through a GRP78-Dependent Pathway in Diabetic Retinopathy.
Shao J; Yin Y; Yin X; Ji L; Xin Y; Zou J; Yao Y
Cell Physiol Biochem; 2017; 43(2):788-800. PubMed ID: 28950253
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-384-3p inhibits retinal neovascularization through targeting hexokinase 2 in mice with diabetic retinopathy.
Xia F; Sun JJ; Jiang YQ; Li CF
J Cell Physiol; 2018 Jan; 234(1):721-730. PubMed ID: 30191948
[TBL] [Abstract][Full Text] [Related]
10. miR-23b-3p induces the cellular metabolic memory of high glucose in diabetic retinopathy through a SIRT1-dependent signalling pathway.
Zhao S; Li T; Li J; Lu Q; Han C; Wang N; Qiu Q; Cao H; Xu X; Chen H; Zheng Z
Diabetologia; 2016 Mar; 59(3):644-54. PubMed ID: 26687158
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding ribonucleic acid urothelial carcinoma-associated 1 promotes high glucose-induced human retinal endothelial cells angiogenesis through regulating micro-ribonucleic acid-624-3p/vascular endothelial growth factor C.
Yan H; Yao P; Hu K; Li X; Li H
J Diabetes Investig; 2021 Nov; 12(11):1948-1957. PubMed ID: 34137197
[TBL] [Abstract][Full Text] [Related]
12. YAP1 is required for the angiogenesis in retinal microvascular endothelial cells via the inhibition of MALAT1-mediated miR-200b-3p in high glucose-induced diabetic retinopathy.
Han N; Tian W; Yu N; Yu L
J Cell Physiol; 2020 Feb; 235(2):1309-1320. PubMed ID: 31313295
[TBL] [Abstract][Full Text] [Related]
13. microRNA-499-3p inhibits proliferation and promotes apoptosis of retinal cells in diabetic retinopathy through activation of the TLR4 signaling pathway by targeting IFNA2.
Liu X; Zhang Y; Liang H; Zhang Y; Xu Y
Gene; 2020 May; 741():144539. PubMed ID: 32160960
[TBL] [Abstract][Full Text] [Related]
14. miR-200-3p suppresses cell proliferation and reduces apoptosis in diabetic retinopathy via blocking the TGF-β2/Smad pathway.
Xue L; Xiong C; Li J; Ren Y; Zhang L; Jiao K; Chen C; Ding P
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33150936
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-148a-3p alleviates high glucose-induced diabetic retinopathy by targeting TGFB2 and FGF2.
Wang J; Yao Y; Wang K; Li J; Chu T; Shen H
Acta Diabetol; 2020 Dec; 57(12):1435-1443. PubMed ID: 32661705
[TBL] [Abstract][Full Text] [Related]
16. miR-92b-3p Promotes Colorectal Carcinoma Cell Proliferation, Invasion, and Migration by Inhibiting FBXW7 In Vitro and In Vivo.
Gong L; Ren M; Lv Z; Yang Y; Wang Z
DNA Cell Biol; 2018 May; 37(5):501-511. PubMed ID: 29638162
[TBL] [Abstract][Full Text] [Related]
17. miR-223-3p targets FBXW7 to promote epithelial-mesenchymal transition and metastasis in breast cancer.
Wang Y; Shi S; Wang Y; Zhang X; Liu X; Li J; Li P; Du L; Wang C
Thorac Cancer; 2022 Feb; 13(3):474-482. PubMed ID: 34953047
[TBL] [Abstract][Full Text] [Related]
18. Elevated microRNA-20b-3p and reduced thioredoxin-interacting protein ameliorate diabetic retinopathy progression by suppressing the NLRP3 inflammasomes.
Wang S; Du S; Lv Y; Wang W; Zhang F
IUBMB Life; 2020 Jul; 72(7):1433-1448. PubMed ID: 32150340
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-155-3p promotes hepatocellular carcinoma formation by suppressing FBXW7 expression.
Tang B; Lei B; Qi G; Liang X; Tang F; Yuan S; Wang Z; Yu S; He S
J Exp Clin Cancer Res; 2016 Jun; 35(1):93. PubMed ID: 27306418
[TBL] [Abstract][Full Text] [Related]
20. MiR-199a-3p inhibits the proliferation, migration, and invasion of endothelial cells and retinal pericytes of diabetic retinopathy rats through regulating FGF7 via EGFR/PI3K/AKT pathway.
Zhou L; Zhang S; Zhang L; Li F; Sun H; Feng J
J Recept Signal Transduct Res; 2021 Feb; 41(1):19-31. PubMed ID: 32586178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
